Tredegar (TG) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
11 Mar, 2026Executive summary
Fourth quarter 2025 net income from continuing operations was $14.5M ($0.42/share) vs. a loss of $7.3M ($-0.21/share) in Q4 2024; full year 2025 net income was $24.1M ($0.69/share) vs. $1.0M ($0.03/share) in 2024.
Net income from ongoing operations (non-GAAP) was $11.0M ($0.32/share) in Q4 2025 vs. $2.0M ($0.06/share) in Q4 2024; full year 2025 was $25.7M ($0.74/share) vs. $17.2M ($0.50/share) in 2024.
Strong Q4 EBITDA performance in Aluminum Extrusions and solid cash flow in High Performance Films, despite challenging market and tariff conditions.
Financial highlights
Consolidated sales for 2025 were $722.9M, up from $598.0M in 2024; Q4 sales were $184.1M, up from $154.0M in Q4 2024.
Consolidated EBITDA from ongoing operations was $58.5M in 2025 vs. $50.5M in 2024; Q4 EBITDA was $18.9M vs. $11.1M in Q4 2024.
Net debt decreased to $28.4M at year-end 2025 from $54.8M at year-end 2024.
Effective tax rate from continuing operations was 21.5% in 2025 vs. -18.8% in 2024.
Outlook and guidance
2026 outlook remains uncertain due to weather-related disruptions and ongoing tariff pressures; surface protection film volumes expected to soften in Q1 2026 due to customer inventory correction and maintenance.
Capital expenditures projected at $20M for Aluminum Extrusions and $3M for High Performance Films in 2026.
Latest events from Tredegar
- Virtual annual meeting to vote on directors, executive pay, and auditor, with strong governance focus.TG
Proxy Filing2 Dec 2025 - Virtual meeting on May 9, 2025, to vote on directors, pay, and auditor ratification.TG
Proxy Filing2 Dec 2025 - Q3 2025 delivered strong profit and EBITDA growth, led by Aluminum Extrusions and lower net debt.TG
Q3 20252 Dec 2025 - Net income and EBITDA fell in Q2 2025 as tariffs and inefficiencies pressured results.TG
Q2 20258 Oct 2025 - Improved Q3 results, Terphane sale, and lower leverage amid ongoing margin pressures.TG
Q3 202413 Jun 2025 - Q2 2024 net income rebounded to $8.8M with broad EBITDA gains and key regulatory decisions ahead.TG
Q2 202413 Jun 2025 - Net income jumped to $10.1M as Terphane sale and tariffs boosted results despite margin pressure.TG
Q1 20256 Jun 2025 - Tredegar posts strong EBITDA growth and sharp debt reduction, returning to profitability in 2024.TG
Q4 20245 Jun 2025